Skip to main content
Overview
News
Events & Presentations
Stock Info
Stock Quote
Analyst Coverage
Financials
Quarterly Results
Annual Reports
SEC Filings
Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Contact the Board
Resources
Investor FAQs
Investor Email Alerts
Investor Contacts
Investor Relations
Corporate Profile
Inotiv, Inc., is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research models and related products and services. The Company’s products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development, all while increasing efficiency, improving data, and reducing the cost of taking new drugs to market. Inotiv is committed to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical R&D projects, all while working together to build a healthier and safer world.
Learn More
Latest News
View All News
Latest Events
View All
Latest Presentation
Latest Quarter Results
Q2
2026
Latest Quarter Results
Financial Statement
of Q2 2026, PDF file, (opens in new window)
See all quarterly reports
SEC Filings
(opens in new window)
Governance Documents
(opens in new window)
Annual Report
(opens in new window)
Environmental, Social and Governance (ESG)
(opens in new window)